Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Levey AS, Inker LA, Coresh J. Chronic kidney disease in older people. JAMA. 2015;314:557–8. https://doi.org/10.1001/jama.2015.6753
2. Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, Gaona- Pineda EB, Lazcano-Ponce E, Martínez-Barnetche J, Alpuche-Arana C, Rivera-Dommarco J. Encuesta Nacional De Salud Y Nutrición 2020 sobre Covid-19. Resultados nacionales. Cuernavaca Morelos: Instituto Nacional de Salud Pública; 2021.
3. Jha JC, Banal C, Chow BS, Cooper ME, Jandeleit-Dahm K. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal. 2016;25:657–84. https://doi.org/10.1089/ars.2016.6664
4. Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL. Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transpl. 2013;28:352–9. https://doi.org/10.1093/ndt/gfs460
5. Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y. Serum levels of soluble secreted alpha-klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exper Nephrol. 2012;16:722–9. https://doi.org/10.1007/s10157-012-0621-7